CBD

Statement from Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D. at March 05, 2020...

Cannabidiol (CBD) has emerged as a potential agent for breast cancer management. In this work, the potential use of cannabidiol...

Cannabidiol (CBD) is highly lipophilic, and its oral bioavailability is known to be very low in humans. In this study,...

Cannabidiol (CBD) and the potential benefit is the current hot topic. Just found this publication by the group of Elka...

Cannabis has been used in pain management since 2900 BC. In the 20th century, synthetic cannabinoids began to emerge, thus...

Article by Omar Sacirbay - mjbizmagazine As an emergency room physician and the founding CEO of Vireo Health, a multistate...

The development of cannabinoids in the pharmaceutical industry has exploded over the past few years. With the gradual liberation of...

See the presentation of Sophie Hughes from Gattefossé at CPhI Worldwide where she talked through a poster presentation on the...

A short introduction to Maisine® CC, the new pharmaceutical oil from Gattefossé, a solubility and oral bioavailability enhancer! Maisine® CC...

Cannabidiol (CBD) has become an industry panacea that’s finding its way into everything from daily supplements to herbal therapies. The...